Thesis (M.S.)--University of North Carolina at Wilmington, 2005. / Includes bibliographical references (leaves: [85]-87)

Thesis (M.S.)--University of Wisconsin--Madison, 1968. / eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references.

Thesis (Ph. D.)--University of Wisconsin--Madison, 1947. / Typescript. Vita. eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references (leaves [92-97]).

Thesis (Ph. D.)--Cleveland State University, 2009. / Abstract. Title from PDF t.p. (viewed July 29, 2009). Includes bibliographical references (p. 105). Available online via the OhioLINK ETD Center and also available in print.

Thesis (M.S.)--West Virginia University, 2005. / Title from document title page. Document formatted into pages; contains vii, 75 p. : ill. (some col.). Includes abstract. Includes bibliographical references (p. 74-75).

Thesis (Ph. D.)--University of Canterbury, 2010. / Typescript (photocopy). Includes bibliographical references. Also available via the World Wide Web.

No description available.

Thesis (M.S.)--Duquesne University, 2009. / Title from document title page. Abstract included in electronic submission form. Includes bibliographical references (p. 82-90) and index.

Erythromycin, a macrolide antibiotic used mainly against gram-positive bacteria has been in clinical use since 1952 (1). Previous pharmacokinetic data published on this antibiotic have been derived predominantly from microbiological assay techniques. However, these techniques are relatively imprecise as well as being non-specific and extremely tedious to perform. A novel high performance liquid chromatographic analysis of erythromycin in human serum and urine using U.V. detection at 200 nm and/or electrochemical detection using both an amperometric and a coulometric electrochemical detector is presented. The method involves a solid phase extraction procedure followed by a simple phase separation step and chromatography on a reverse phase column. In order to select the optimum U.V. detector for this analysis, five "state of the art" detectors were compared in terms of their signal-to-noise ratios at U.V. wavelengths between 200 and 210 nm. A known metabolite des-N-methylerythromycin is readily detectable using U.V. detection, whilst another metabolite/degradation product anhydroerythromycin is not seen using U.V. detection but is readily observable using an electrochemical detector. The method has a limit of sensitivity of 0.25 μg/mL and 1.00 μg/mL in serum and urine respectively (U.V. detection) and is sufficiently sensitive to monitor serum and urine concentrations of erythromycin in man after administration of a single 500 mg erythromycin stearate tablet. / KMBT_363 / Adobe Acrobat 9.53 Paper Capture Plug-in

Envelope proteins of the human immunodefiency virus (HIV) use the cell surface CD-4 molecule of target cells to initiate infection which eventually lead to the acquired immunodeficiency syndrome (AIDS). HIV-1 strains form three groups, namely the M, N and O, with the former group further divided into at least ten equidistant subtypes or clades (i.e. A through J) classified on the basis of sequence homologies in the envelope gene. Recombinant envelope proteins expressed in transfected Chinese hamster ovary (CHO) cells were isolated and purified here (~ 0.01 mg yield). An economical but efficient purification procedure using affinity chromatography and freeze-drying was developed. The results obtained through SDS-PAGE, western blotting, specific ELISA (using Galanthus nivalis a lectin with affinity for ENV glycoproteins) and partial sequencing confirmed the purity (~ 85 - 90 %) and identity of the proteins. Since these proteins were derived in a clade A (Uganda) and B (USA) environment we anticipated limited crossreactivity with immune responses induced in a subtype C (RSA) environment. This was assessed using ELISA (titers of 1000) and western blot analysis. The ability to induce apoptosis was used to demonstrate functionality of the purified protein (Results showed that in-vitro induction of apoptosis (65 %) using the continuous cell line PM1 was achieved). / Dr. Debra Meyer